DUNEDIN, New Zealand, April 12, 2017 /PRNewswire/ -- Pacific Edge is proud to announce that its recent clinical study on Cxbladder Monitor's clinical performance and utility has been published in the ...

DUNEDIN, New Zealand, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Bladder cancer diagnostics provider, Pacific Edge Diagnostics, has been notified by Novitas1 that the LCD: Biomarkers for Oncology (L35396) ...

Newly published research demonstrates that Cxbladder out performs other non-invasive bladder cancer diagnostics, announced Pacific Edge, Ltd. The new research comparing and ranking four widely used ...

Pacific Edge Signs Agreement Extending Commercial Partnership with MidCentral District Health Board, to Encompass All Cxbladder Tests for Application Across the Clinical Pathway Cancer diagnostics ...

Pacific Edge Limited (NZX:PEB), a cancer diagnostics company developing and commercializing a suite of non-invasive tests for the detection and management of bladder cancer, announces today the ...

Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) has today launched Cxbladder Resolve, the fourth product in the Cxbladder suite of bladder cancer diagnostic tests. Cxbladder Resolve, a ...

Providers using BxLink can easily access Cxbladder's suite of tests, allowing faster integration of these groundbreaking diagnostics into everyday practice. The platform's advanced capabilities ensure ...

Two Christchurch urologists have words of caution about the marketing of a urine test for detection of bladder cancer direct to patients. This week Dunedin biotech Pacific Edge said it would launch an ...

Pacific Edge Limited ( (PFGTF)) has shared an update. Cancer diagnostics firm Pacific Edge has secured the first order for its Cxbladder Triage Plus test from Townsville University Hospital, following ...